38 Annual National Conference

Transcription

38 Annual National Conference
Association for Medical Education and Research in Substance Abuse
38th Annual
National Conference
“Building Connections: Bridging Interdisciplinary
Leadership in Substance Use Education,
Research, Care, and Policy”
November 6-8, 2014
JW Marriott Union Square
500 Post Street, San Francisco, California
Jointly Provided By
Funding for this conference was made possible (in part) by a grant to the AMERSA National Conference R13DA15046 from
the National Institute on Drug Abuse. The views expressed in written conference materials or publications and by speakers
and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does
mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Conference Objectives
At the conclusion of this educational activity, participants should be able to:
• Recognize the current social marketing trends of tobacco, alcohol, and other drugs to young adults and their impact
• Assess the benefits and risks of e-cigarettes as a smoking cessation tool
• Evaluate the legislative and educational issues surrounding the prescription opioid misuse problem
• Apply the latest strategies for detecting, treating, and managing substance use disorders in their patients
• Continue collaboration and mentoring relationships with professional
colleagues
AMERSA’s Mission
AMERSA, founded in 1976, is an organization whose mission is to improve
health and well-being through interdisciplinary leadership in substance use
education, research, clinical care and policy.
Executive Committee
Daniel P. Alford, MD, MPH - President
J. Paul Seale, MD - Vice-President
Lauren Matukaitis Broyles, PhD, RN - Secretary
Babalola Faseru, MD, MPH - Treasurer
Kimber P. Richter, PhD, MPH - Immediate Past-President
Hillary Kunins, MD, MPH, MS - Member-at-Large
Elizabeth M. Pace, MSM, RN, CEAP - Member-at-Large
Alexander Y. Walley, MD, MSc - Member-at-Large
Constance M. Weisner, DrPH, MSW - Member-at-Large
Adam Gordon, MD, MPH - Editor-in-Chief, Substance Abuse
David C. Lewis, MD - Emeritus Director
Doreen MacLane-Baeder - Executive Director AMERSA
1
AMERSA Program Planning Committee
AMERSA Planning Committee Co-Chairs
Victoria A. Osborne, PhD, MSW
Paula J. Lum, MD, MPH
Abstract Co-Chairs
Carol Dawson Rose, PhD, RN, MS
Sion Kim Harris, PhD, CPH
Workshop Chair
Harold Perl, PhD
Evaluation Chair
Lauren M. Broyles, PhD, RN
Planning Advisory Committee Members
Susan Adams, PhD, MSN
Daniel P. Alford, MD,MPH
Amanuel Asfaw, MA
Soraya Azari, MD
Sewit Bereket, MPH
Nicolas Bertholet, MD, MSc
Michael Bierer, MD, MPH
Lauren Broyles, PhD, RN
Mady Chalk, PhD, MSW
Gerald Cochran, PhD, MSW
Diana Coffa, MD
Carol Dawson Rose, PhD, RN, MS
Gail D’Onofrio, MD, MS
Nadia Fairbairn, MD
Babalola Faseru, MD, MPH
Deborah Finnell, DNS, RN
Leigh Fischer, MPH
Valerie Gruber, PhD, MPH
Erik Gunderson, MD
William Haning, MD
Kathleen Hanley, MD
Christina Holt, MD, MSc, MA
Theresa Kim, MD
Julie Kmiec, DO
Hillary Kunins, MD, MPH, MS
Robert Lindblad, MD
Kate Malliarakis, CNP, MAC, RN
Marianne T. Marcus, EdD, RN, FAAN
Christine Maynie-Francois, MD, MSc
Sara McEwen, MD, MPH
Jessica Merlin, MD, MBA
Claudia Mooney, MD
Seonaid Nolan, FRCPC
Elizabeth Pace, MSM, RN, CEAP
Amee Patel, PhD
Harold Perl, PhD
Megan Petra, MSW
Karran Phillips, MD, MSc
Cara Poland, MD
Marianne Pugatch, MSW, LICSW
Brie Reimann, MPA
John Renner, MD
Kimber Richter, PhD, MPH
Laura Rivera, PhD
Sheryl Ryan, MD
Ken Saffier, MD
Debra Sprague, MA
Jean Sullivan, RN
Babak Tofighi, MD
Dan Vinson, MD, MSPH
2
AMERSA Task Forces
Task forces meet for months to years, to achieve specific AMERSA goals and objectives.
Currently, there is one AMERSA Task Force: Physician Education Task Force. All meeting
participants are invited to attend this task force on Thursday 11:30am-1:00pm. AMERSA
members who wish to start a new task force should contact the Executive Director of
AMERSA.
Special Interest Groups
Special Interest Groups, less structured than task forces, provide an opportunity for
attendees to have a focused discussions on various topics. Currently, there are two
AMERSA Special Interest Groups - the Nursing Initiative Interest Group and the Social
Work Initiative Interest Group. All meeting participants are invited to attend these
interest groups on Thursday 11:30am-1:00pm. AMERSA members who wish to start a
new interest group should contact the Executive Director of AMERSA.
One-on-One Mentoring
One-on-one mentoring sessions are an opportunity for attendees to meet with national
leaders in the field of substance use. The mentoring can focus on career development
and/or research, teaching, and related issues. If you would like to schedule time to meet
with a mentor, please stop by the registration desk. A list of this year’s mentors and areas
of interest is included in your registration packet.
Physician Continuing Medical Education Credits
Accreditation: This activity has been planned and implemented in accordance with the
accreditation requirements and policies of the Accreditation Council for Continuing
Medical Education through the joint providership of the Warren Alpert Medical School
of Brown University and the Association for Medical Education and Research in Substance
Abuse. The Warren Alpert Medical School is accredited by the ACCME to provide continuing
medical education for physicians.
Credit Designation: The Warren Alpert Medical School designates this live activity for a
maximum of 14 AMA PRA Category 1 Credits™. Physicians should only claim credit
commensurate with the extent of their participation in the activity.
(Nov. 6 - 6.25; Nov. 7 - 5.0; Nov. 8 -2.75)
Social Work Continuing Education Credits
13 total credit hours will be provided for Counselors and Social Workers by the Ohio
Counselor, Social Worker and Marriage and Family Therapist Board (approval #MCS111401)
(Nov. 6 - 5.25; Nov. 7 - 3.5; Nov. 8 - 4.25)
Nursing Continuing Education Credits
19 total credit hours will be provided by the District of Columbia Board of Nursing which is
accredited as a provider of continuing education. (Nov. 6 - 9.5; Nov. 7 - 5.0; Nov. 8 - 4.5)
Counselor Continuing Education Credits
19 total credit hours will be provided by NAADAC, the Association for Addiction
Professionals, which is accredited as a provider of continuing education.
(Nov. 6 - 9.5; Nov. 7 - 5.0; Nov. 8 - 4.5)
3
Wednesday, November 5, 2014
3:00 - 6:00 pm
5:00 - 8:00 pm 7:00 - 9:00 pm skyline a-c
Conference Registration
AMERSA Executive Committee Meeting
Poster Set-Up
7:00 - 5:00 pm
foyer
8:00 - 8:30 am
metropolitan a 8:30 - 9:30 am metropolitan a
9:45 - 11:15 am metropolitan a
11:30 – 1:00 pm
board room
11:30 – 1:00 pm
rd
3
flr. gallery booths
1:00 – 2:00 pm
2:15 – 3:15 pm
metropolitan a
3:30 – 5:00 pm
metropolitan b
metropolitan c
salon i
3:30 – 5:00 pm
5:15 – 6:15 pm
metropolitan a
6:30 – 8:00 pm
skyline a-c
8:30 – 10:00 pm
metropolitan a
Conference Registration
Thursday, November 6, 2014
Welcome and Opening Remarks
Daniel P. Alford, MD, MPH - AMERSA President
Plenary Session - Selling Sin or Sainthood? Tobacco Marketing
and Counter-Marketing Strategies to Reach Young Adults
Presented by: Pamela Ling, MD, MPH
Plenary Panel Session - Addressing the Prescription Opioid Misuse
Epidemic: Should we Legislate or Educate?
Presented by: Daniel P. Alford, MD, MPH,
Jane C. Ballantyne, MD, FRCA and Daniel Ciccarone, MD, MPH
Past Presidents’ Council Meeting
Task Force Meetings (Physician Education), Special Interest Group Meetings (Nursing, Social Work)
Scientific Research, Programmatic and Curricula Evaluation
Presentations (Please see page 7-8 for presenters and rooms)
Betty Ford Award Plenary Session – Building a Research Career Focused on Alcohol Use in a Stigmatized and Marginalized
Population Group
Presented by: Tonda L. Hughes, PhD, RN, FAAN
Skills-Based Workshops
Overdose Prevention to Improve Opioid Safety in Clinical Practice:
Naloxone Rescue Kits for Patients Who Use Opioids
Phillip O. Coffin, MD, MIA, Alexander Y. Walley, MD, MSc and
Michelle Geier, PharmD
Getting your Article from an Idea to Publication in a Peer Reviewed
Addiction Journal
Adam J. Gordon, MD, MPH, Ingrid Binswanger, MD, MPH,
Lauren Broyles, PhD, RN, Babalola Faseru, MD, MPH,
Marianne Pugatch, MSW, LICSW and Richard Saitz, MD, MPH
Creating a Collaborative “Road Map”: Family Based Harm
Reduction Treatment Planning
Stephanie Renno, LCSW
Scientific Research, Programmatic and Curricula Evaluation
Presentations (Please see page 8 for presenters and rooms)
New Member/First Time Attendee Orientation
Welcome Reception, Scientific Poster Session, and
Substance Abuse Journal Awards
2014 Substance Abuse Journal Best Paper
Awarded to: Conrad L. Woolsey, PhD, CHES, CC-AASP
2014 Substance Abuse Journal Most Downloaded Article
Awarded to: Lauren M. Broyles, PhD, RN
2014 Substance Abuse Journal Best Peer Reviewer
Awarded to: Jennifer McNeely, MD, MS
Movie Night - The Fix - A documentary film by Laura Naylor
4
Friday, November 7, 2014
7:15 – 8:15 am
skyline b-c
8:45 – 9:45 am
NIDA Breakfast Session - What do we Know about Addressing Substance Use in Medical Settings?
Presenter: Harold Perl, PhD
(All are welcome!)
10:00 – 11:30 am
metropolitan c
Skills-Based Workshops
Scientific Research, Programmatic and Curricula Evaluation
Presentations (Please see page 8-9 for presenters and rooms)
Treating Opioid Addiction Using Buprenorphine Within an
Integrated Group Medical Visit
Charles Preston, PhD, Sara Doorley, MD, Elizabeth Echeverria, LCSW
and Cheryl Ho, MD
*Funding for this initiative was made possible (in part) by Physicians’ Clinical Support System for Medication Assisted Treatment (1U79TI024697) from SAMHSA. The views expressed in written conference materials or publications and by speakers and
modera tors do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
metropolitan b
Behavior Change in Our Patients and Ourselves: Interdisciplinary,
Experiential Teaching to Improve Motivational Interviewing Skills in Clinical Practice
Paul M. Grossberg, MD
salon i
Using Social Media to Teach and Disseminate Information about Addiction
Christine Maynié-François, MD and Richard Saitz, MD, MPH
10:00 – 11:30 am
Scientific Research, Programmatic and Curricula Evaluation
Presentations (Please see page 9-10 for presenters and rooms)
11:45 – 2:15 pm
skyline b-c
Program Planning Lunch Session (All are welcome! Please join us as we plan the 2015 conference!)
2:30 – 4:00 pm
metropolitan a
Plenary Session - A Spicy Debate – Should Medical Providers
Recommend E-Cigarettes to their Patients as a Smoking
Cessation Tool?
Presented by: Neal Benowitz, MD and Michael B. Siegel, MD
4:15 – 5:15 pm
metropolitan a
5:45 – 7:30 pm
skyline b-c
John P. McGovern Award Plenary Session – How Addiction
Research Can Have the Greatest Impact on US Alcohol
and Drug Policy
Presented by: The Honorable Patrick J. Kennedy
W. Anderson Spickard, Jr. Excellence in Mentorship Award Recipient
David A. Fiellin, MD
Award presented by: Jeanette Tetrault, MD, FACP, E. Jennifer Edelman, MD, MHS and William C. Becker, MD
John P. McGovern Award Recipient
The Honorable Patrick J. Kennedy
Award presented by: Daniel P. Alford, MD, MPH
Awards Reception and Auction
New Investigator/Educator Award Recipient
Nicolas Bertholet, MD, MSc
Award presented by: Richard Saitz, MD, MPH
5
Saturday, November 8, 2014
6:00 – 7:00 am
7:15 – 8:15 am
metropolitan c
Annual Fun Run-Walk
9:00 – 10:15 am
metropolitan a
Plenary Session - Presentation of Awards
and Best Abstract Presentations
Best Workshop Award Recipient
“A New Tool for Hard Times: Using Prescription Monitoring
Programs to Reduce Drug Abuse”
Awarded to: Jeffrey D. Baxter, MD
Award presented by: Harold Perl, PhD
The John Nelson Chappel Best Abstract Award
“Cultural Based Intervention to Affect Substance Abuse Among a Native American Adolescent Population”
Awarded to: John Lowe, RN, PhD, FAAN
Award presented by: Sion Kim Harris, PhD
10:30 – 12:00 pm
Best Abstract Award - Program and Curricula
“Application of the SCORe Methodology to Assess the Effect of
SBIRT Program Adherence on Binge-Drinking Outcomes”
Awarded to: Bonnie G. McRee, PhD, MPH
Award presented by: Sion Kim Harris, PhD
salon i
Motivational and Cognitive-Behavioral Interventions for Diverse Adults with Methamphetamine Use Disorders
Valerie A. Gruber, PhD, MPH, Abigail W. Batchelder, MA, MPH and Donna Whitfield, MA
metropolitan c
A New Tool for Hard Times: Using Prescription Monitoring Programs to Reduce Drug Abuse
Jeffrey Baxter, MD
2013 Best Workshop Award Winner
metropolitan b
Integrating Dialectical Behavior Therapy with the Twelve Steps: A
Non-Pharmacologic Approach to Managing Emotion Dysregulation
in Addiction Treatment
Bari K. Platter, MS, RN, PMHCNS-BC and Osvaldo Cabral, MA, LPC, CAC III
10:30 – 12:00 pm
Scientific Research, Programmatic and Curricula Evaluation
Presentations (Please see page 10 for presenters and rooms)
12:15 – 2:00 pm
skyline a
Program Planning Luncheon Session (All are welcome! Please join us as we plan for the 2015 conference!)
2:00 – 2:30 pm
skyline a
Business Meeting
ADJOURN
Morning Yoga Session and Healthy Breakfast Bar
Best Research Abstract Award - Semi-Finalist
“ED-Initiated Buprenorphine/Naloxone Treatment for Opioid
Dependence versus Standard and Facilitated Referrals:
A Randomized, Controlled Trial”
Awarded to: Gail D’Onofrio, MD, MS
Award presented by: Sion Kim Harris, PhD
Skills-Based Workshops
6
Scientific Research, Programmatic and
Curricula Evaluation Presentations
Thursday, November 6, 2014 • 1:00 - 2:00 pm
Session 1.1 • Salon III
Technological Approaches to Identifying and Treating Substance Use
Moderator: Carol Dawson Rose, PhD, RN
•
•
•
•
Mobile Phone Messaging for Office-Based Buprenorphine Patients - Babak Tofighi, MD
Computer-Facilitated Screening and Physician Brief Advice: Effects on Heavy Episodic
Drinking Among Adolescents - Kateryna Kuzubova MA, PC-CR
Internet-Based Brief Intervention for Young Men with Unhealthy Alcohol Use:
A Randomized Trial in a General Population Sample - Nicolas Bertholet, MD, MSc
Not Ready for Prime Time? An Internet-Based SBIRT Intervention in an Urban, Safety-Net HIV Clinic - Roland Zepf, MS, RN, ACRN
Session 1.2 • Salon II
HIV and Substance Use
Moderator: Todd Korthuis, MD, MPH
•
•
•
•
Patterns of Methadone Use on Antiretroviral Therapy Discontinuation - Paxton Bach, MD
From Risk Networks to Care Institutions: Shifts in Social Capital from HIV+ Drug Users’
Perspectives on Engagement in HIV Treatment - Yohansa Fernández, LMSW
Ready or Not? HIV Provider Acceptability of Extended-Release Naltrexone - Todd Korthuis, MD, MPH
A Complex Interplay between Social Isolation, Stigma and Substance Use: Results from a
Qualitative Study of MSM with and without HIV - E. Jennifer Edelman, MD, MHS
Session 1.3 • Salon I
Screening and Brief Intervention
Moderator: Sharon Levy, MD, MPH
• Validation of Self-Administered Single Item Screening Questions (SISQs) for Unhealthy Alcohol and other Drug Use in Primary Care Patients at Two Sites - Jennifer McNeely, MD, MS
• Physician Performance of Screening and Brief Intervention after Residency Graduation
- J. Paul Seale, MD
• A Brief Self-Administered Substance Use Screening Tool for Primary Care: Two-Site
Validation Study of the Substance Use Brief Screen (SUBS) - Jennifer McNeely, MD, MS
• Screening for Alcohol Use Among Adolescents with Chronic Medical Conditions
- Sharon Levy, MD, MPH
Session 1.4 • Metropolitan B
SBIRT Clinical Training
Moderator: Brett Harris, DrPH
• Teaching Residents SBIRT Skills for Alcohol Use: Using Chart-Stimulated Recall to Assess Curricular Impact - Maria Wamsley, MD
• SBIRT Education for Both the Mind and the Heart? Assessing Changes in Medical
Residents’ Attitudes to Working with Drinkers - Michael Mitchell, MA
• WAM! Week of Addiction Medicine: An Intensive Curriculum for Internal Medicine-
Primary Care Interns - Elenore Patterson, MD, MPH
• Implications for Training in Adolescent Screening, Brief Intervention, and Referral to
Treatment: Knowledge, Attitudes, and Perceptions of School-Based Health Center
Providers - Brett Harris, DrPH
7
Session 1.5 • Metropolitan C
Opiates: Dose, Substitution and Relapse
Moderator: George Jay Unick, PhD, MSW
•
•
•
•
The Role of Opiate Dose in Adherence and Illicit Drug Use - Diana Coffa, MD and
Elisabeth Powelson, MD, MS
Opiate Substitution: An Opportunity to Adequately Treat Tuberculosis in People Who
Inject Drugs - Claire Elise Burdet, BSc, MD
Factors Associated with Opioid Relapse Following Release from Jail - Karen Cropsey, PsyD
National Trends in Heroin-Related Skin and Soft Tissue Infections and Associations with Heroin Market Characteristics - George Jay Unick, PhD, MS
Thursday, November 6, 2014 • 3:30-5:00 pm
Session 2.1 • Salon II
Addressing Disparities in Substance Use Treatment
Moderator: Audrey Begun, MSW, PhD
• Access to and Payment for Buprenorphine Treatment in Ohio - Ted Parran, MD and
Joseph Muller, MS4
• Treatment and Self-Help Availability in Disadvantaged and Minority Neighborhoods
- Katherine Karriker-Jaffe, PhD
• Housing Associated with Achieving Abstinence after Detoxification in Adults with
Addiction - Tae Woo Park, MD
• Income Variability by Race in Tobacco Outlet Density in Maryland - Renee Johnson, PhD
• Barriers to Engaging in Addiction Treatment Following Release from Incarceration
- Audrey Begun, MSW, PhD
Session 2.2 • Salon III
Pain
Moderator: Jessica Merlin, MD, MBA
•
•
•
•
•
Current Chronic Prescription of Opioids and Muscle Relaxants by Era of HIV Diagnosis
- Jessica Merlin, MD, MBA
‘Typologies of Opioid Analgesic Users and Patterns of Prescribing in New York City:
A Qualitative Analysis’ - Alexandra Harocopos, MS
The Role of the Hospital-Based Physician in Long Term Opioid Use - Susan Calcaterra, MD, MPH
Hunting for the Happy Medium - Management of a Patient Stable on Suboxone Needing
Emergent Opioid Analgesia for Pain - A Case of Tolosa Hunt Syndrome
- Mitika Kanabar, MD, MPH and Anna Lembke, MD
Prescription Opioid Use is Associated with Increased Mortality in the Reasons for
Geographic and Racial Differences in Stroke (REGARDS) Study - Yulia Khodneva, MD, PhD
Friday, November 7, 2014 • 8:45 - 9:45 am
Session 3.1 • Salon II
Adolescents/Young Adults
Moderator: Sion Kim Harris, PhD
•
•
•
•
Adolescent SBIRT Implementation in Pediatric Primary Care: Results from a Randomized
Trial in an Integrated Health Care Delivery System - Stacy Sterling, MS, MPH
Sexual Violence in the Context of Drug Use among Young Adult Nonmedical Users of
Prescription Opioids in New York City - Lauren Jessell, MSW
Bere Responsabile: Hazardous Alcohol Use and Cultural Adjustment among U.S. College Students Abroad in Italy - Michael Mitchell, MA
References to Marijuana in Popular Music, 2009-2011 - Renee Johnson, PhD
8
Session 3.2 • Metropolitan A
Opiate Antagonists and Resuscitation
Moderator: Peter Friedmann, MD, MPH
• Effectiveness of Extended-Release Naltrexone (XR-NTX) among Criminal Justice-Involved, Persons with Opioid Use Disorders - Peter Friedmann, MD, MPH
• Provision of Intra-Nasal Naloxone to Patients Taking Chronic Opioids at San Francisco General Hospital: Implementation and Challenges - Soraya Azari, MD
• Naloxone Administration in Veterans for Overdose Rescue Therapy (NAVORT)
- Cassandra Clement, PharmD and Christopher Stock, PharmD
• Factors Associated with Opioid Overdose Resuscitation - Gerald Cochran, PhD, MSW
Session 3.3 • Salon III
Interdisciplinary Substance Abuse Training and Impact
Moderator: Richard L. Brown, MD, MPH
• The Use of Simulated Patients in the Education of Mental Health Professionals in a Graduate Substance Abuse Program - Marianne Saint-Jacques, PhD
• Screening, Brief Intervention, and Referral to Treatment: Pre-Service Interprofessional Education of Undergraduate and Graduate Nursing Students - Marie Fioravanti, DNP, RN
• Teaching Screening, Brief Intervention, and Referral to Treatment (SBIRT) to Social Work
Students: Results from a Combined Online Training and Simulated Client Experience
- Victoria Osborne, PhD, MSW
• A Paraprofessional-Administered SBIRT Reduces Medicaid Costs Over Subsequent Two Years - Richard L. Brown, MD, MPH
Friday, November 7, 2014 • 10:00-11:30 am
Session 4.1 • Salon II
Smoking/E-Cigarettes/Marijuana
Moderator: Babalola Faseru, MD, MPH
• Predictors of Engagement in Post-Discharge Quitline Counseling among Hospitalized Smokers - Taneisha Scheuermann, PhD
• Prevalence of E-Cigarette use and Associations between E-Cigarettes use and Cigarette Cessation Attempt and Abstinence among Kansas Adults - Trevor Christensen, MPH
• E-Cigarette Use among Smokers with Serious Mental Illness - Jodi Prochaska, PhD, MPH
• Telephone Counseling versus Text Messaging for Supporting Post-Discharge Quit Attempts among Hospitalized Smokers in Brazil: A Feasibility Study - Erica Cruvinel, PhD Student
• Quitting Smoking in the Face of Co-occurring Acute Psychiatric and Addictive Disorders: What is Possible? - Smita Das, MD, PhD, MPH
• “Everybody Says Weed is Good for the Baby”: Beliefs and Attitudes Regarding Perinatal Marijuana Use from the Perspectives of Pregnant Women Who Report Continued Use - Judy Chang, MD, MPH
Session 4.2 • Metropolitan A
Overdose
Moderator: Alexander Walley, MD, MSc
• Opiate Overdose Death in San Francisco in 2010 and 2011: An Emergence of a Citywide
Prescription Opiate Overdose Epidemic - Adam Visconti, MD, MPH
• Non-Fatal Overdoses as a Risk Factor for Subsequent Fatal Overdose among Injection Drug Users - Alexander Caudarella, MDCM
• Fatal and Non-Fatal Overdose after Narcology Hospital Discharge among HIV-Infected Russians - Alexander Walley, MD, MSc
• Development of Case Criteria to Define Pharmaceutical Opioid and Heroin Overdoses in Clinical Records - Ingrid Binswanger, MD
9
• “Closing in on Death”: Explaining Geographical Patterns of Heroin Overdose in the United States - Sarah Mars, PhD
• Overdose Education and Naloxone for Patients on Chronic Opioids: A Qualitative Study of
Medical Staff - Ingrid Binswanger, MD
Session 4.3 • Salon III
Structural Gaze and Substance Use
Moderator: Gerald Cochran, PhD, MSW
• Marked Variation in US State Policies on Opioid Prescribing - Joanna Starrels, MD, MS
• Planning for Health Care Reform in an Integrated Health System: Anticipated Impact on
Addiction Treatment and HIV Care - Cynthia Campbell, PhD
• Defining Non-Medical Use of Prescription Opioids within Health Insurance Claims Data:
A Systematic Review - Gerald Cochran, PhD, MSW
• Strategies to Increase the Sustainability of Medication Assisted Treatment - James Ford II, PhD
• Developing Prescription Monitoring Program Predictors for Drug Overdose Death
- Christina Holt, MD, MSc, MA
Saturday, November 8, 2014 • 10:30 - 12:00 pm
Session 5.1 • Salon II
Buprenorphine Impact and Treatment Approaches
Moderator: George Woody, MD
• I Feel Safe Here: “The Group Medical Visit Model for Buprenorphine Maintenance
Treatment - Mariya Masyukova, ScB and Aaron Fox, MD, MS
• HIV Risk Reduction With Buprenorphine-Naloxone or Methadone: Findings From a
Randomized Trial - George Woody, MD
• Buprenorphine Plus Clonidine Increases Time to Lapse and Reduces Heroin Craving at Low-to-Moderate Stress Levels - Karran Phillips, MD, MSc
• Unobserved ‘Home’ Induction onto Buprenorphine: Outcomes at Year 7
- Elenore Patterson, MD, MPH
• Injection Drug Users Prefer Harm Reduction Agencies to other Potential Sites for
Buprenorphine Treatment - Aaron Fox, MD, MS and Adam Chamberlain, MS III
Session 5.2 • Salon III
Alcohol SBI
Moderator: Nicolas Bertholet, MD, MSc
• Effects of Brief Intervention on Subclasses of Injured Patients Who Drink at Risk Levels
- Gerald Cochran, PhD, MSW
• Treatment Dismantling Study to Identify the Active Ingredients in Personalized Feedback
Interventions for Hazardous Alcohol Use: Randomized Control Trial
- John Cunningham, PhD
• Implementation of Screening, Brief Intervention, and Referral to Treatment in New York City Primary Care Practices as a Public Health Strategy to Address Unhealthy Alcohol Use
- John McAteer, LCSW-R
• Internet-Based Primary Prevention Intervention for Alcohol Use: A Randomized Trial
- Nicolas Bertholet, MD, MSc
• Effectiveness of Screening and Brief Intervention in Reducing Risky Drinking: Results from an Implementation Study in Primary Care Setting - Felecia Chi, MPH
10
Save The Date!
November 5-7, 2015
for the
39th Annual National Conference
Sincere Thanks to our Exhibitors
CEDAR - Univ. of Colorado Hospital
Orexo US, Inc.
Proove Biosciences, Inc.
Routledge Journals
Stratus EMR
Substance Abuse Research Education and Training (SARET)